Chitosan-coated gold NPs with the ability to target fibrin were used to quantitate the amount of thrombolysis in a cerebral thromboembolic model of stroke in mice following treatment with intravenous tissue plasminogen activator (tPA). The gene discussed is PLAT; the disease is Stroke.